News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
61,214 Results
Type
Article (3874)
Company Profile (8)
Press Release (57332)
Multimedia
Podcasts (16)
Webinars (6)
Section
Business (25014)
Career Advice (69)
Deals (3845)
Drug Delivery (16)
Drug Development (4238)
Employer Resources (12)
FDA (873)
Job Trends (1122)
News (29597)
Policy (1332)
Tag
Academia (252)
Accelerated approval (2)
ADA (7)
Allergies (14)
Alliances (5216)
ALS (16)
Alzheimer's disease (157)
Antibody-drug conjugate (ADC) (35)
Approvals (900)
Artificial intelligence (144)
ASCO (8)
Autoimmune disease (44)
Automation (10)
Bankruptcy (34)
Belgium (8)
Best Places to Work (788)
BIO (10)
Biologics (6)
BIOSECURE Act (2)
Biosimilars (26)
BioSpace Insights (37)
Biotechnology (11)
Bladder cancer (11)
Brain cancer (6)
Breast cancer (28)
Cancer (379)
Cardiovascular disease (60)
Career advice (68)
Career pathing (6)
CAR-T (39)
CDC (1)
CDMO (26)
Cell therapy (103)
Cervical cancer (1)
Clinical research (3608)
Collaboration (273)
Commercialization (3)
Compensation (38)
Complete response letters (5)
COVID-19 (160)
CRISPR (11)
CRO (1)
C-suite (259)
Cystic fibrosis (19)
Data (523)
Decentralized trials (1)
Denatured (8)
Depression (15)
Dermatology (11)
Diabetes (45)
Diagnostics (645)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (2)
Drug discovery (91)
Drug pricing (15)
Duchenne muscular dystrophy (12)
Earnings (4777)
Editorial (8)
Employer resources (11)
ESMO (11)
Events (5997)
Executive appointments (234)
FDA (1121)
Fragile X (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (1009)
Gene editing (24)
Generative AI (14)
Gene therapy (71)
GLP-1 (81)
Government (154)
Guidances (30)
Healthcare (1311)
Hematology (5)
HIV (4)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (34)
Immuno-oncology (8)
Indications (8)
Infectious disease (189)
Inflammatory bowel disease (20)
Inflation Reduction Act (4)
Influenza (7)
Intellectual property (25)
Interviews (6)
IPO (1798)
IRA (8)
Job creations (321)
Job search strategy (61)
JPM (10)
Kidney disease (24)
Labor market (20)
Layoffs (46)
Leadership (5)
Legal (282)
Licensing (7)
Liver cancer (7)
Longevity (6)
Lung cancer (41)
Lymphoma (23)
Machine learning (11)
Management (4)
Manufacturing (123)
Marketing (1)
MASH (36)
Medical device (1361)
Medtech (1393)
Mergers & acquisitions (2200)
Metabolic disorders (149)
mRNA (24)
Multiple sclerosis (5)
Multispecific (1)
NASH (4)
Netherlands (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (299)
Neurotech (1)
NextGen: Class of 2026 (968)
Non-profit (306)
Now hiring (3)
Obesity (66)
Opinion (62)
Ovarian cancer (16)
Pain (18)
Pancreatic cancer (7)
Parkinson's disease (32)
Partnered (7)
Patents (34)
Patient recruitment (85)
Patient selection (6)
Peanut (7)
People (9357)
Peptides (3)
Pharmaceutical (4)
Phase 1 (1198)
Phase 2 (1666)
Phase 3 (993)
Pipeline (759)
Policy (32)
Postmarket research (104)
Preclinical (650)
Press Release (6)
Prostate cancer (20)
Psychedelics (5)
Radiopharmaceuticals (43)
Rare diseases (96)
Real estate (596)
Recruiting (6)
Regenerative medicine (2)
Regulatory (1213)
Reports (10)
Research institute (181)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (2)
Schizophrenia (7)
Series A (273)
Series B (195)
Sickle cell disease (4)
Special edition (5)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (2235)
Supply chain (5)
Switzerland (1)
Tariffs (4)
Tax incentives (1)
The Weekly (8)
Vaccines (41)
Venture capital (140)
Weight loss (33)
Women's health (12)
Worklife (1)
Date
Today (10)
Last 7 days (49)
Last 30 days (201)
Last 365 days (2354)
2026 (1963)
2025 (2481)
2024 (2960)
2023 (3121)
2022 (5569)
2021 (4920)
2020 (4778)
2019 (4504)
2018 (3579)
2017 (3044)
2016 (2553)
2015 (2965)
2014 (2109)
2013 (1741)
2012 (1862)
2011 (2083)
2010 (2176)
Location
Africa (69)
Alabama (7)
Alaska (2)
Arizona (24)
Arkansas (5)
Asia (4206)
Australia (527)
California (1222)
Canada (1001)
China (134)
Colorado (28)
Connecticut (48)
Delaware (19)
Europe (9176)
Florida (79)
Georgia (51)
Hawaii (2)
Idaho (5)
Illinois (67)
India (28)
Indiana (31)
Iowa (2)
Japan (66)
Kansas (8)
Kentucky (6)
Louisiana (7)
Maine (6)
Maryland (79)
Massachusetts (717)
Michigan (21)
Minnesota (37)
Mississippi (1)
Missouri (20)
Montana (2)
Nebraska (1)
Nevada (22)
New Hampshire (8)
New Jersey (196)
New Mexico (6)
New York (244)
North Carolina (141)
North Dakota (1)
Northern California (612)
Ohio (46)
Oklahoma (5)
Oregon (5)
Pennsylvania (240)
Puerto Rico (3)
Rhode Island (6)
South America (99)
South Carolina (10)
Southern California (468)
Tennessee (14)
Texas (122)
United States (3543)
Utah (50)
Virginia (28)
Washington D.C. (2)
Washington State (65)
West Virginia (1)
Wisconsin (22)
61,214 Results for "nextech venture".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Beyond equity: Why venture debt is reshaping European biotech
In this episode of Denatured, you’ll hear from Jennifer McMahon, partner at Seroba and Joey Mason, venture partner at Claret Capital. We dig into how venture debt buys time when equity can’t and how Europe’s funding gaps, tranching habits and slower urgency shape who uses it well.
October 8, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Venture capital
5 biggest venture capital raises of Q3 2026
Venture capital continued to flow into biopharma in the third quarter, though experts pointed out that investors remained selective, preferring to put their money behind advanced and derisked assets, as well as AI-driven drugmakers.
October 7, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Illumisoft Appoints Former 3M Growth Ventures Leader Bill Weber as Chief Strategy Officer
October 8, 2026
·
3 min read
Press Releases
Karoo Health Announces Oversubscribed $16.2 Million Series A Co-Led by 7wire Ventures and Allumia Ventures
July 21, 2026
·
4 min read
Press Releases
Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
October 20, 2026
·
6 min read
Press Releases
Lifespan Vision Ventures Leads Remedium Bio’s Series A Financing
August 10, 2026
·
2 min read
Press Releases
Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
October 29, 2026
·
8 min read
Press Releases
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
September 10, 2026
·
3 min read
Press Releases
ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
September 9, 2026
·
4 min read
Press Releases
Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
September 28, 2026
·
4 min read
1 of 6,122
Next
